Publication | Closed Access

Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation

Molecular PharmacologyMedicinal ChemistryNovel Structural ClassDrug TargetBiochemistryMedicineNatural SciencesRational Drug DesignNf-κb ActivationPotent InhibitorsDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryInhibitory ActivityDrug Discovery